Summary
The survival of 64 consecutive patients with disseminated midgut carcinoid tumours was compared in a retrospective study with that of 25 consecutive patients with sporadic malignant endocrine pancreatic tumours treated according to similar surgical principles. The presence of hepatic metastases implied a worse prognosis in neuroendocrine tumours of pancreatic rather than midgut origin. This infers that these tumour types must be separated when treatments are evaluated.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Arnold, R., Trautman, M. E., Creutzfeldt, W., Benning, R., Benning, M., Neuhaus, C., Jürgensen, R., Stein, K., Schäfer, H., Bruns, C. & Dennler, H. J. (1996). Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut 38: 430–438.
Carty, S. E., Jensen, R. T. & Norton, J. A. (1992). Prospective study of aggressive resection of metastatic pancreatic endocrine tumours. Surgery 112: 1024–1032.
Dousset, B., Saint-Marc, O., Pitre, J., Soubrane, O., Houssin, D. & Chapuis, Y. (1996). Metastastic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg 20: 908–915.
Foster, J. H. & Lundy, J. (1981). Liver metastases. Curr Probl Surg 18: 157–202.
Galland, R. B. & Blumgart, L. H. (1986). Carcinoid syndrome. Surgical management. Br J Hosp Med 35: 166–170.
Gould, V. E., Jao, W., Chejfec, G., Banner, B. F. & Bonomi, P. (1984). An overview: neuroendocrine carcinomas of the gastrointestinal tract. Sem Diagn Pathol 1: 13–18.
Lang, H., Oldhafer, K. J., Weimann, A., Schlitt, H. J., Scheumann, G. F. W., Flemming, P., Ringe, B. & Pichlmayr, R. (1997). Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 225: 347–354.
Le Treut, Y. P., Delpero, J. R., Dousset, B., Cherqui, D., Segol, P., Mantion, G., Hannoun, L., Benhamou, G., Launois, B., Boillot, O., Domergue, J. & Bismuth, H. (1997). Results of liver transplantation in the treatment of metastatic tumors: a 31-case French multicentric report. Ann Surg 225: 355–364.
McEntee, G. P., Nagorney, D. M., Kvols, L. K., Moertel, C. G. & Grant, C. S. (1990). Cytoreductive hepatic surgery for neuroendocrine tumours. Surgery 108: 1091–1096.
Moertel, C. G., Johnson, M. C., McKusik, M. A., Martin, J. K. Jr, Nagorney, D. M., Kvols, L. K., Rubin, J. & Kunselman, S. (1994). The management of patients with advanced carcinoid tumors and islet cell carcinoma. Am Int Med 120: 302–309.
Norton, J. A. (1997). Surgical management of carcinoid tumours: Role of debulking and surgery for patients with advanced disease. Digestion 55: 98–103.
Que, F. G., Nagorney, D. M., Batts, K. P., Linzl, J. & Kvols, L. K. (1995). Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 169: 36–43.
Wängberg, B., Westberg, G., Tylén, U., Tisell, L. E., Jansson, S., Nilsson, O., Johanson, V., Scherstén, T. & Ahlman, H. (1996). Survival of patients with disseminated midgut carcinoid tumours after aggressive tumour reduction. World J Surg 20: 892–899.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Johanson, V., Tisell, L., Olbe, L. et al. Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin. Br J Cancer 80, 1259–1261 (1999). https://doi.org/10.1038/sj.bjc.6690494
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690494